Clinical Trials Logo

Clinical Trial Summary

Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial.

Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.


Clinical Trial Description

Phototherapy (PT) is widely used and assumed to be safe as well as effective in reducing total bilirubin (TB) levels. Our recent NICHD Network Trial showed that aggressive use of phototherapy reduces neurodevelopmental impairment (NDI), but may increase deaths among ELBW infants. Among ventilator treated infants <750 g birth weight (BW) (n =696), conservative Bayesian analyses (using a neutral prior probability) identified a 99% (posterior) probability that aggressive phototherapy reduced profound NDI but a 99% probability that it increased deaths relative to conservative phototherapy. The possibility that PT increases deaths among high risk infants is also suggested by the Collaborative Phototherapy trial (performed in the 1970s), the only large RCT in which LBW infants were randomly assigned to receive PT or no PT. The relative risk for death among those randomized to PT relative to those randomized to no PT was 1.32 (0.9-1.82) among all LBW infants and 1.49 (0.93-2.40) among ELBW infants. These findings are consistent with a major increase in mortality but have been ignored because the p was >0.05, an error often made in ignoring important potential treatment hazards when power is limited.

Multiple studies, most performed decades ago in larger infants, found that short on/off cycles of PT (e.g. 15 min on/60 min off, 1 h on/3 h off, or 1 h on/1 h off ) are as effective as uninterrupted PT to reduce TSB. (Cycles with >6 h off PT do not appear to be as effective as uninterrupted PT). The clinical use of uninterrupted rather than cycled PT appears to be based largely on the assumption that PT is safe for all infants. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01944696
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact Jon E Tyson, MD
Phone 713-500-5651
Email jon.e.tyson@uth.tmc.edu
Status Recruiting
Phase N/A
Start date March 2014
Completion date January 2018

See also
  Status Clinical Trial Phase
Completed NCT00360204 - Improving Health Outcomes for New Mothers and Babies Phase 3
Completed NCT00383318 - Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia N/A
Completed NCT00115544 - Safety and Pharmacology of Stanate Phase 2
Completed NCT01622699 - Implementation of a Transcutaneous Bilirubinometer N/A
Terminated NCT00741117 - Conjugated Hyperbilirubinemia and Pulse Oximetry N/A
Completed NCT00288600 - Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease Phase 4
Completed NCT02774434 - Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age N/A
Completed NCT01550627 - Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy Phase 0
Completed NCT00653874 - Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates Phase 3
Recruiting NCT03564678 - Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia Phase 2
Recruiting NCT04897113 - Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old N/A
Completed NCT00635375 - Comparative Study of Phototherapy for Hyperbilirubinemia N/A
Completed NCT03195998 - Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
Terminated NCT02685189 - Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)
Completed NCT02446951 - Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Terminated NCT01136577 - Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn N/A
Completed NCT04271098 - The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries
Completed NCT02691156 - Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
Completed NCT00004381 - Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia Phase 2
Completed NCT00004382 - Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns Phase 2